DoW Reconstructive Transplant, Investigator-Initiated Research Award
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The fiscal year 2026 Reconstructive Transplant Research Program Investigator-Initiated Research Award, solicitation HT942526RTRPIIRA, is a funding opportunity from the Defense Health Agency designed to advance the science and clinical practice of vascularized composite allotransplantation. The program supports research ranging from basic to translational phases, including preclinical animal models and clinical research in human subjects, provided the work demonstrates solid scientific rationale and military-relevant utility for Service Members, Veterans, and the general public. Notably, clinical trials are strictly prohibited. Awards are capped at 1.0 million dollars with a maximum period of performance of three years. Applicants must be registered in SAM.gov and submit their proposals through eBRAP or Grants.gov, with a pre-application deadline of October 21, 2026, and a full application deadline of November 4, 2026. Required documentation includes a project narrative, statement of work, impact statement, and evidence of preliminary or published data. Evaluation follows a two-tier process consisting of a peer review for technical merit and a programmatic review for military health relevance and portfolio composition. Key requirements include the disclosure of foreign affiliations for all key personnel and a strategy for the inclusion of women and minorities in any proposed clinical research.
General Info
Place of Performance
Not specifiedSet-Aside
Timeline
Response Deadline
Organization & Contact Information
Full Description
Summary: The fiscal year 2026 (FY26) Reconstructive Transplant Research Program (RTRP) Investigator-Initiated Research Award supports studies that have the potential to make an important contribution to reconstructive transplant research, patient care, and/or quality of life. All projects must demonstrate solid scientific rationale with military-relevant utility. The Investigator-Initiated Research Award does not support clinical trials.
Distinctive Features:
· Scope: Applications may focus on any phase of research from basic through translational, including preclinical studies in animal models, and clinical research in human subjects or human anatomical substances.
· Study Design and Feasibility: The study design should be rigorous and support maximal reproducibility and translational feasibility. A strong statistical plan with appropriate power analysis is important.
· Impact: Project results should have the potential for long- and short-term impact on the reconstructive transplant research field and/or patient community. Projects should address at least one of the FY26 RTRP Focus Areas.
· Preliminary Data: Preliminary and/or published data that are relevant to reconstructive transplantation and support the rationale for the proposed research must be included.
· Military Relevance: All projects must be responsive to the health care needs of military Service Members and/or Veterans recovering from traumatic injury, and/or their Family members, caregivers, or clinicians, as well as the general public. Collaboration with military researchers and clinicians is encouraged but not required.
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Health Agency Contracting Activity - Dhaca
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
